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the target registration, and we used the Dice similarity coefficient to 
classify the registration quality. A secondary aim was to find a FRE-
cutoff value that indicates a good MR-CT-fusion. A third aim was to 
see if there was an additional gain using 4 versus 3 gold fiducials in a 
rigid registration of the MR- and CT-series. 
Materials and Methods: Retrospectively we analysed 18 prostate 
patients treated with curative radiotherapy up to 78 Gy. All patients 
had 3 or 4 gold fiducials implanted in the prostate. All patients had 
performed MR-series within 1 hour after the CT-series, and the two 
series were fused through a rigid registration procedure in the dose 
planning system Oncentra (Elekta). Migration of the fiducials and 
deformation of the prostate can lead to an increased FRE. We 
simulated a systematic displacement of the most cranial fiducial. This 
influenced the fusion of CT- and MR-series, and the FRE and Dice 
similarity coefficients were compared. We simulated a systematic 
displacement in the X- and Y- direction of the fiducial of up to 4 mm. 
We also calculated a value that classified the spread of the fiducials in 
the prostate. The value is calculated from the sum of the distances 
between all the fiducials divided by the sum of the maximum distance 
between all the fiducials if they were located on the prostate wall. 
Results: We found that the spread of the fiducials is very important. A 
small FRE-value from fiducials that are closely spaced can hide a large 
target registration error. We found that a spread of the fiducials with 
a value of 0.6 of the maximum possible spread of fiducials in the 
prostate is a cut-off value that can be used to indicate that a small 
FRE correlates well with a good target registration. We found a clear 
indication that 4 fiducials give a better target registration than 3 
fiducials even when they indicate the same fiducial registration error. 
4 fiducials are more robust when it comes to errors from migration of 
the fiducials and deformation of the prostate. 
Conclusions: It is vital that the 4 fiducials implanted are well-spread 
in the prostate. A small FRE-value does not necessarily indicate a good 
target registration, and the FRE-value should be used in coherence 
with a value that indicates the spread of the fiducials. 4 fiducials are 
superior to 3 fiducials in most cases.  
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Purpose/Objective: Quality assurance for radiotherapy (QART) aims 
to improve patient outcome in Head and Neck (H&N) cancer patient 
included in prospective studies. Three levels of QART were proposed: 
center’s Facility Questionnaire and External Review Dosimetry 
Assessment with Dummy runs (QA level II), prospective Individual Case 
Reviews (ICRs) for 15% of patients (QA level III) and prospective ICRs 
for all patients (QA level IV). The purpose of this study is to assess the 
outcome impact (QAOI) and cost-effectiveness (QACEA) of the three 
levels of QART program, for H&N cancer patient included in the 
EORTC 22071-24071 protocol. 
Materials and Methods: The non-activated phase III of postoperative 
chemo-radiotherapy with EGFR inhibition would have included 600 
patients in 15 European centers. The study primary endpoint was 
local-tumor control on a two years follow-up, expressed as life-years 
without relapse. The follow-up of patients was modeled using a multi-
state model. Parameters of the model were derived from EORTC 
studies, TROG 0202 and RTOG 0525 prospective studies. Simulations 
were performed with a probabilistic sensitivity analysis. Results for 
each QART level were expressed as percentage of mortality and local 
failure on 2 years, and in survival times and life-days without relapse 
on 2 years.  
Results: For the QAOI, the estimated incremental percentage of local 
failure was -2.1% [95%CI: -5.9; -1.8], -4.9% [95%CI: -8.3; -1.5] and -
2.7% [95%CI: -4.6; -1.4], for an increase QART level from II to III, II to 
IV and III to IV, respectively. The estimated incremental survival times 
was 8 days [95%CI: -7; 24], 18 days [95%CI: 4; 34], and 10 days [95%CI: 
4; 18], for an increase QART level from II to III, II to IV and III to IV, 
respectively. The QACEA will be detailed during the congress. 
Conclusions: Patient treated with an increase QART level were 
significantly less likely to recur locally.  
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Purpose/Objective: Hypofractionated stereotactic ablative 
radiotherapy (SABR) for small volume lung tumours precisely delivers 
ablative doses using multiple fixed gantry angle beams or volumetric 
arc therapy (VMAT). The high dose per fraction can result in 
significant delivery times and flattening filter free (FFF) beams 
delivered at much higher dose rates may be advantageous. A study at 
our institution compared dose distributions and delivery accuracy of 
one and two arc VMAT plans created with standard and FFF beams to 
determine appropriate planning class solutions and verification 
methods for lung SABR treatments.  
Materials and Methods: Treatment plans were prepared on suitable 
lung datasets for SABR deliveries of 54Gy in 3 fractions. One and two 
arc VMAT plans were optimised and calculated for standard 6MV 
beams (600MU/min) and 6MV FFF beams (1400MU/min). Analysis of 
the resulting dose distributions included conformity index and organ 
at risk (OAR) doses. Deliveries were verified by in-phantom point dose 
measurements and fluence measurements in 2 dose planes using a 2D 
ion chamber array. 
Results: Plans comprised a single 360° arc or two co-planar 195°arcs 
orientated to avoid the contra-lateral lung. All resulting dose 
distributions satisfied pre-defined dose and dose volume constraints 
when using the same optimisation objectives and priorities regardless 
of energy or beam arrangement. There was a slight improvement in 
conformity index with the FFF energy. The two arc technique resulted 
in lower mean and maximum doses to the contra-lateral lung however 
there was no significant difference in V20Gy and V12.5Gy for the 
combined lung. Total beam on time was approximately 5.6 minutes 
for 6MV and 2.5 minutes for 6MV FFF. Target volume point dose 
measurements in geometrical and semi-anatomical phantoms were 
within 2.5% of calculated for all deliveries. Measured point doses 
outside the target volumes were up to 6.5% different to calculated 
however dose gradients in these low dose regions may have 
contributed to the higher discrepancies. Fluence measurements with a 
2D ion chamber array showed 100% of points within the 3%/3mm dose 
difference / distance to agreement threshold for points above 20% of 
the maximum dose.  
Conclusions: Class solutions for one and two arc VMAT deliveries 
resulting in acceptable dose distributions for SABR lung treatments 
can be achieved with 6MV and 6MV FFF beams. Analysis of the 
resultant dose distributions showed no significant differences between 
plans. There was good agreement between planned and delivered 
point doses within the target volumes and OARs and between planned 
and delivered fluence regardless of beam orientation or energy. FFF 
deliveries are significantly faster than standard which may improve 
the patient experience. The choice of single arc or two arc plans is 
dependant on isocentre position in order to avoid collision as the 
gantry rotates around the patient. 
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Purpose/Objective: To assess the accuracy of plastic scintillation 
detectors (PSDs) for real time in-vivo measurement of the dose to the 
anterior rectal wall for IMRT and to determine the clinical utility of 
daily monitoring of rectal dose for prostate cancer patients. 
Materials and Methods: 58 in-vivo measurements were performed 
during prostate IMRT for the 1st two patients of an IRB approved 
protocol. During each monitored fraction two PSDs were attached to 
the anterior surface of an endorectal balloon to monitor the dose 
delivered to the rectal wall. The balloon was inserted into the patient 
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rectum during treatment for prostate immobilization, which 
positioned the imbedded detectors in direct contact with the anterior 
rectal wall. Prior to treatment, patients were scanned on the 
treatment couch of a CT-on-rails Linear Accelerator, which allowed 
precise localization of the detectors. During the patient treatment, 
dose information was collected and displayed in real time, providing a 
visual measure of dose rate and cumulative dose as a function of time. 
Patient treatment was re-planned with the two detectors contoured 
on the new CT dataset to calculate the expected cumulative dose to 
the detectors for that corresponding fraction. The daily recalculated 
dose was compared to the measurement of the delivered dose for the 
corresponding fraction. 
Results: The average deviation between the measured dose and the 
treatment planning system calculated dose over the 58 measurements 
after removing 5 outliers was -1.5% with a standard deviation of 4.0%. 
The minimum deviation observed was 0.26% (calculated dose: 191.8 
cGy, measured dose: 191.3 cGy). The maximum observed deviation for 
a detector positioned in contact with the anterior rectal wall was -
8.1% (184.7 cGy versus 169.7 cGy) which could indicate organ motion. 
Patient in-vivo results are displayed in Table 1 with in-phantom results 
for comparison. Daily in-vivo results for patient number 2 are 
displayed in Figure 1. Due to the real time nature of this detector it 





Conclusions: This PSD system has proved to be an excellent in-vivo 
dosimeter, capable of measuring dose received by a patient with high 
accuracy as treatment is being delivered. This permits daily 
monitoring of the dose received by patients. The detector has the 
potential to detect internal organ motion and is certainly capable of 
alerting users if the patient is not set up properly on the basis of 
larger dose deviations (20% or above). Additionally, the detector is 
non invasive, and can be implemented with no alteration of current 
treatment practices.  
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Purpose/Objective: Radiotherapy (RT) of advanced non-small cell 
lung cancer (NSCLC) results in poor survival and high risk of lung 
toxicity. Radiotherapy in deep inspiration breath hold (DIBH) may 
reduce lung toxicity as lung volume increases. Prior to clinical 
implementation, evaluation of voluntary DIBH feasibility and 
reproducibility is necessary, since NSCLC patients often have poor 
lung function, which can further impair during a RT course. 
Materials and Methods: Nine patients were included in the study so 
far (six declined). Besides standard imaging for RT planning (4D 
computed tomography (CT) and DIBH CT), all patients had three 
additional imaging sessions including three consecutive DIBH CT at 
treatment fractions 2, 16 and 31. All DIBHs were visually guided. An 
optical marker based system was used for respiratory monitoring, 
enabling comfortable voluntary DIBH. Gating window of 2-3 mm was 
chosen at individual level, adjusted to each patient's performance, 
when coaching prior to RT planning. The patients' capability to 
increase lung volume and to perform repeated DIBH lasting 20 seconds 
or more throughout the RT course was considered a measure of 
feasibility. The reproducibility of DIBH level was evaluated as intra- 
and inter-fractional variations in DIBH lung volume and intra-
fractional changes in tumour position. As changes in tumour position 
were evaluated by manual registrations, intra-observer uncertainty of 
the registration process was evaluated as well. 
Results: Lung volume increased with DIBH compared to free breathing 
by 60% (range 35-87%; p < 0.0001; paired t-test). There was a slight 
non-significant trend (p=0.23; paired t-test) towards an increased lung 
volume at DIBH between the planning CT and the treatment days' DIBH 
CTs: 4% ± 6% (mean ± SD). No further variations in lung volume were 
observed throughout the treatment course: changes on days 16 & 31 
compared to day 2 were 0% ± 3%. Intra-fractional changes in lung 
volume were small, 1.1%± 0.8%. Intra-observer uncertainty in tumour 
registration was small, 0.2 mm ± 0.6mm three-dimensionally (3D). 
Intra-fractional changes in 3D tumour position were 2.1 mm ± 1.4 mm. 
No trend was observed throughout the course. Intra-fractional 3D 
tumour position change exceeded 3 mm in two DIBH CT sets, one 
patient suffered pneumonia at the time, the other patient had a 2 mm 
difference in chest excursion between the DIBHs on the particular 
day. The patients, who refused to enter the protocol (6/15) were on 
average 10 years older (p=0.014; t-test), which could be a potential 
bias of the study. 
Conclusions: DIBH seems feasible and reproducible intra- and inter-
fractionally during a course of NSCLC RT and is well tolerated. We are 
continuously accruing more patients in the protocol in order to 
strengthen these encouraging first results on stability and 
reproducibility of visually guided DIBH with external optical system for 
respiratory monitoring. 
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Purpose/Objective: The aim of the study was to increase total 
marrow irradiation (TMI) treatment effectiveness and time efficiency 
while minimizing the dose for non-skeletal structures. 
Materials and Methods: Twelve patients with multiple myeloma were 
treated by the following TMI method. As a target, all skeletal bones 
were contoured (Eclipse, Varian Inc.) excluding hand bones, jawbone, 
mandible and ethmoid bone. Critical organs were contoured for 
conformal avoidance. Due to the limitation in the longitudinal couch 
travel (effectively up to 135 cm), the total marrow irradiation delivery 
had to be split into two independent plans: HFS and FFS patient 
orientation. To avoid an unnecessary second CT scan, the FFS CT 
volume was generated by flipping the original HFS CT volume with our 
in-house written software. The upper body TMI plan (UTMI) covered 
the body from the head to 11 cm above knee joint, for which the 
helical tomotherapy technique was applied. The lower body TMI plan 
(LTMI) covered the body from the feet up to 6 cm below the knee 
joint, for which the direct tomotherapy technique was applied (two 
opposite fields of 90°-270°). All plans were implemented using the 
TomoHD treatment planning system (version 1.02; Accuray Inc.). The 
optimization goal was to achieve that a minimum of 85% of the target 
volume receives at least 99% of the prescription dose (12 Gy). 
Fractionation scheme was 3 x 4 Gy (three consecutive days, one 
irradiation a day). 
Results: In twelve patients, the following mean doses were obtained 
[mean±SD, Gy]: UTMI-target 12.15±0.06; LTMI-target 12.35±0.08; brain 
7.64±0.32; lenses 2.24±0.28; oral cavity 4.79±0.49; lungs 7.98±0.11; 
heart 7.51±0.29; liver 7.91±0.40; kidneys 6.46±0.27; bowel 7.51±0.26; 
bladder 6.53±0.15. Mean irradiation time [mean±SD, minutes] for 
UTMI was 35.15±3.50, and for LTMI was 12.66±0.79 (Fig.1). 
 
